We are live on ! Find out more
VI

Versor Investments Portfolio holdings

AUM $40.8M
1-Year Est. Return 93.59%
This Fund
S&P 500
This Quarter Est. Return
+32.36%
1 Year Est. Return
+93.59%
3 Year Est. Return
+200.36%
5 Year Est. Return
+581.76%
10 Year Est. Return
AUM
$1.98B
AUM Growth
+$509M
Cap. Flow
+$313M
Cap. Flow %
15.8%
Top 10 Hldgs %
41.07%
Holding
424
New
142
Increased
65
Reduced
84
Closed
132

Sector Composition

Rank Sector Weight
1 Healthcare 20.54%
2 Consumer Discretionary 15.84%
3 Technology 14.74%
4 Industrials 12.14%
5 Financials 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CZR
1
DELISTED
Caesars Entertainment Corporation
CZR
$84.6M 4.28%
6,223,357
+48,922
+0.8% +$619K
MLNX
2
DELISTED
Mellanox Technologies, Ltd.
MLNX
$82.8M 4.18%
706,287
+68,587
+11% +$7.79M
KEM
3
DELISTED
KEMET Corporation
KEM
$82.2M 4.15%
+3,037,146
New +$73.8M
WBC
4
DELISTED
WABCO HOLDINGS INC.
WBC
$81.6M 4.13%
602,243
+69,942
+13% +$9.43M
ADSW
5
DELISTED
Advanced Disposal Services Inc
ADSW
$81M 4.09%
2,462,899
+270,804
+12% +$8.88M
ACIA
6
DELISTED
Acacia Communications Inc
ACIA
$80.6M 4.08%
1,189,276
+134,731
+13% +$8.93M
CBPX
7
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$80.4M 4.06%
+2,205,831
New +$72.6M
WMGI
8
DELISTED
Wright Medical Group Inc
WMGI
$80.3M 4.06%
+2,634,244
New +$69M
INXN
9
DELISTED
Interxion Holding N.V.
INXN
$80M 4.04%
+954,285
New +$79.7M
LPT
10
DELISTED
Liberty Property Trust
LPT
$79.1M 4%
+1,316,982
New +$75.5M
AMTD
11
DELISTED
TD Ameritrade Holding Corp
AMTD
$77.8M 3.93%
+1,565,743
New +$67.9M
AYR
12
DELISTED
Aircastle Ltd
AYR
$76.1M 3.85%
+2,376,255
New +$68.6M
CY
13
DELISTED
Cypress Semiconductor
CY
$74.8M 3.78%
3,204,862
+344,600
+12% +$8.06M
TIF
14
DELISTED
Tiffany & Co.
TIF
$73.8M 3.73%
+552,459
New +$65.3M
AGN
15
DELISTED
Allergan plc
AGN
$71.1M 3.59%
371,886
-5,211
-1% -$940K
MDCO
16
DELISTED
Medicines Co
MDCO
$63.3M 3.2%
+744,836
New +$49.7M
WCG
17
DELISTED
Wellcare Health Plans, Inc.
WCG
$62.8M 3.18%
190,325
-63,753
-25% -$19.1M
RARX
18
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$47.1M 2.38%
+1,002,649
New +$44.3M
ACHN
19
DELISTED
Achillion Pharmaceuticals
ACHN
$45.3M 2.29%
+7,515,675
New +$43.5M
BOLD
20
DELISTED
Audentes Therapeutics, Inc
BOLD
$43.7M 2.21%
+729,714
New +$27.4M
ARQL
21
DELISTED
Arqule Inc
ARQL
$39.6M 2%
+1,983,957
New +$23M
THOR
22
DELISTED
Synthorx, Inc. Common Stock
THOR
$33.4M 1.69%
+478,453
New +$13.7M
OMN
23
DELISTED
OMNOVA Solutions Inc.
OMN
$29.1M 1.47%
2,877,791
+924,076
+47% +$9.34M
WLH
24
DELISTED
WILLIAM LYON HOMES
WLH
$25.6M 1.3%
+1,282,439
New +$26.2M
CARO
25
DELISTED
Carolina Financial Corp.
CARO
$18.8M 0.95%
+435,077
New +$17.1M

Similar funds

Versor Investments's Q4 2019 Portfolio in Review

As of Q4 2019, Versor Investments held 424 positions worth $1.98B, up 35% from $1.47B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Versor Investments deployed $313M of net new capital in Q4 2019, opening 142 new positions and adding to 65 existing holdings. Its largest new stake was Interxion Holding N.V.: 954,285 shares worth $80M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $19.1M trimmed.

  • Versor Investments's largest Q4 2019 buy was Interxion Holding N.V.: 954,285 shares worth $80M.
  • Versor Investments added most to WABCO HOLDINGS INC. in Q4 2019, an estimated $9.43M increase.
  • Versor Investments's biggest Q4 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $19.1M.
  • Versor Investments fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $79.5M.
  • Versor Investments's ten largest holdings make up 41% of its $1.98B portfolio in Q4 2019.
  • Versor Investments opened 142 new positions and closed 132 in Q4 2019.
  • Versor Investments's portfolio value rose 35% quarter-over-quarter to $1.98B.

Based on Versor Investments's 13F filing for Q4 2019, filed 10 Feb 2020.